Diagnostic value of p53 immunohistochemistry in Barrett's esophagus: An endoscopic study

被引:27
作者
Khan, S
Do, KA
Kuhnert, P
Pillay, SP
Papadimos, D
Conrad, R
Jass, JR [3 ]
机构
[1] Univ Queensland, Dept Surg, Greenslopes Hosp, Brisbane, Qld, Australia
[2] Queensland Inst Med Res, Sullivan & Nicolaides Pathol Lab, Brisbane, Qld 4006, Australia
[3] Univ Queensland, Sch Med, Dept Pathol, Herston, Qld 4006, Australia
[4] Univ Queensland, Ctr Stat, Brisbane, Qld, Australia
关键词
esophagus; Barrett's; dysplasia; p53;
D O I
10.1080/00313029800169076
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The aim of this study was to establish the diagnostic utility of p53 immunohistochemistry in Barrett's esophagus. Three pathologists reviewed endoscopic biopsy specimens and one surgical specimen derived from 102 subjects in a prospective follow-up series. Dysplasia was graded as negative, indefinite, low grade and high grade. p53 staining was assessed as negative, weak or patchy and strong. Kappa coefficients for interobserver agreement for the three combinations of observer pairs were moderate to substantial (0.48, 0.55 and 0.68) for dysplasia and substantial to near perfect (0.77, 0.82 and 0.89) for p53 immunostaining. In the consensus grading achieved far dysplasia, strong p53 staining was recorded in 0/79 samples that were negative or indefinite for dysplasia, 5/15 (33%) examples of low grade dysplasia and 7/8 (87%) examples of high grade dysplasia, Non-dysplastic p53 positive glands were seen in specimens from two subjects harbouring dysplasia or cancer elsewhere. Two p53 positive specimens were, upon review and discussion, re-assigned from low-to high-grade dysplasia. It is concluded that p53 immunohistochemistry facilitates the interpretation of Barrett's epithelium but need only be employed to confirm a suspected diagnosis of dysplasia and assist with the distinction between low-and high-grade dysplasia.
引用
收藏
页码:136 / 140
页数:5
相关论文
共 38 条
[1]   HIGH-GRADE DYSPLASIA IN THE COLUMNAR-LINED ESOPHAGUS [J].
ALTORKI, NK ;
SUNAGAWA, M ;
LITTLE, AG ;
SKINNER, DB .
AMERICAN JOURNAL OF SURGERY, 1991, 161 (01) :97-100
[2]  
BARRETT NR, 1957, SURGERY, V41, P881
[3]  
BERENSON MM, 1978, CANCER, V41, P554, DOI 10.1002/1097-0142(197802)41:2<554::AID-CNCR2820410223>3.0.CO
[4]  
2-V
[5]  
BLOUNT PL, 1991, CANCER RES, V51, P5482
[6]   CLONAL ORDERING OF 17P AND 5Q ALLELIC LOSSES IN BARRETT DYSPLASIA AND ADENOCARCINOMA [J].
BLOUNT, PL ;
MELTZER, SJ ;
YIN, J ;
HUANG, Y ;
KRASNA, MJ ;
REID, BJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) :3221-3225
[7]   THE INCIDENCE OF ADENOCARCINOMA IN COLUMNAR-LINED (BARRETTS) ESOPHAGUS [J].
CAMERON, AJ ;
OTT, BJ ;
PAYNE, WS .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (14) :857-859
[8]   CLINICAL IMPLICATIONS OF P53 GENE MUTATION IN THE PROGRESSION OF BARRETTS EPITHELIUM TO INVASIVE ESOPHAGEAL CANCER [J].
CASSON, AG ;
MANOLOPOULOS, B ;
TROSTER, M ;
KERKVLIET, N ;
OMALLEY, F ;
INCULET, R ;
FINLEY, R ;
ROTH, JA .
AMERICAN JOURNAL OF SURGERY, 1994, 167 (01) :52-57
[10]   A COEFFICIENT OF AGREEMENT FOR NOMINAL SCALES [J].
COHEN, J .
EDUCATIONAL AND PSYCHOLOGICAL MEASUREMENT, 1960, 20 (01) :37-46